OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection
Fengling Feng, Jiaoshan Chen, Jin Zhao, et al.
Viruses (2021) Vol. 13, Iss. 11, pp. 2243-2243
Open Access | Times Cited: 7
Fengling Feng, Jiaoshan Chen, Jin Zhao, et al.
Viruses (2021) Vol. 13, Iss. 11, pp. 2243-2243
Open Access | Times Cited: 7
Showing 7 citing articles:
S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 16
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 16
Update on the Measurement of "Soluble Angiotensin Converting Enzyme 2" in Plasma and its Emerging Significance as a Novel Biomarker of Cardiovascular and Kidney Diseases: A Concise Commentary
Jean Amiral, Rémy Ferol
Transfusion and Apheresis Science (2025) Vol. 64, Iss. 2, pp. 104090-104090
Closed Access
Jean Amiral, Rémy Ferol
Transfusion and Apheresis Science (2025) Vol. 64, Iss. 2, pp. 104090-104090
Closed Access
Targeting SARS-CoV-2 and host cell receptor interactions
Siew Pheng Lim
Antiviral Research (2022) Vol. 210, pp. 105514-105514
Open Access | Times Cited: 15
Siew Pheng Lim
Antiviral Research (2022) Vol. 210, pp. 105514-105514
Open Access | Times Cited: 15
COVID-19 therapies: do we see substantial progress?
Lucyna Matusewicz, Marlena Golec, Aleksander Czogalla, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 8
Lucyna Matusewicz, Marlena Golec, Aleksander Czogalla, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 8
Up, up, down, down: the structural biology of the SARS-CoV-2 spike protein and how it cheats the immune system
Sabrina Stäb, Nicholas M. Pearce, Dale E. Tronrud, et al.
Crystallography Reviews (2024), pp. 1-44
Open Access | Times Cited: 1
Sabrina Stäb, Nicholas M. Pearce, Dale E. Tronrud, et al.
Crystallography Reviews (2024), pp. 1-44
Open Access | Times Cited: 1
Rational design of AAVrh10-vectored ACE2 functional domain to broadly block the cell entry of SARS-CoV-2 variants
Minchao Li, Jiaoshan Chen, Yajie Liu, et al.
Antiviral Research (2022) Vol. 205, pp. 105383-105383
Open Access | Times Cited: 6
Minchao Li, Jiaoshan Chen, Yajie Liu, et al.
Antiviral Research (2022) Vol. 205, pp. 105383-105383
Open Access | Times Cited: 6
S protein, ACE2 and Host Cell Proteases in SARS-CoV2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword?
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
(2022)
Open Access | Times Cited: 1
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
(2022)
Open Access | Times Cited: 1
